Revance Therapeutics Inc. buy Maxi_Scalibusa
Start price
17.02.19
/
50%
€15.82
Target price
03.04.19
€27.06
Performance (%)
-14.60%
End price
03.04.19
€13.51
Summary
This prediction ended on 03.04.19 with a price of €13.51. The prediction for Revance Therapeutics Inc. disappointed with a performance of -14.60%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1,36 % | -2,16 % | 2,08 % | 52,68 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % | 32,60 % | 88,75 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % | 58,27 % | 82,31 % |
| iShares S&P 500 | -1,66 % | -0,70 % | 22,96 % | 66,08 % |
Comments by Maxi_Scalibusa for this prediction
In the thread Revance Therapeutics Inc. diskutieren
(Stop Loss Kurs erreicht)